Efficacy and Safety of Subcutaneous Prophylaxis with Concizumab in Patients with Hemophilia a or B with Inhibitors: Results from explorer4, a Phase 2, Randomized, Open-Label, Controlled Trial
暂无分享,去创建一个
V. Jiménez‐Yuste | C. Hollensen | G. Castaman | A. Shapiro | G. Young | T. Matsushita | S. Zupancic-Salek | L. Hvitfeldt Poulsen | Katarina Cepo